NCT03962907View on ClinicalTrials.gov

Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

1,318

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

June 30, 2020

Conditions

Staphylococcus AureusOrthopaedic SurgerySurgical Site InfectionPrevention

Interventions

DRUG

Chlorhexidine, Lifo-Scrub sol 4%®, 500ml, B. Braun

5 - day decolonization procedure prior elective surgery. In carriers with Chlorhexidine daily showers and Mupirocin twice a day nasal ointment. In non-carriers Chlorhexidine showers will be used.

DRUG

BACTROBAN® Nasal ong

Mupirocin, BACTROBAN® Nasal ong, 3g, GSK

Trial Locations (1)

3006

Sonnenhofspital, Lindenhofgruppe, Bern

All Listed Sponsors

lead

Lindenhofgruppe AG

INDUSTRY

NCT03962907 - Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery | Biotech Hunter | Biotech Hunter